Crews Bank & Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$600K Sell
7,676
-194
-2% -$15.7K 0.08% 135
2026
Q1
$682K Sell
7,870
-38
-0.5% -$3.64K 0.1% 118
2025
Q4
$760K Sell
7,908
-317
-4% -$30.8K 0.11% 107
2025
Q3
$783K Sell
8,225
-68
-0.8% -$6.25K 0.11% 109
2025
Q2
$723K Sell
8,293
-797
-9% -$67.6K 0.11% 108
2025
Q1
$817K Sell
9,090
-363
-4% -$32.5K 0.14% 97
2024
Q4
$755K Buy
+9,453
New +$818K 0.13% 104

Other funds holding MDT

Crews Bank & Trust's MDT Position: Q2 2026 in Review

Crews Bank & Trust reduced its Medtronic (MDT) stake by 2.5% in Q2 2026, selling an estimated $15.7K and leaving 7,676 shares worth $600K. The position accounts for 0.08% of the portfolio, ranked #135.

Crews Bank & Trust first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $817K in Q1 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Crews Bank & Trust held 7,676 shares of Medtronic worth $600K as of Q2 2026.
  • Crews Bank & Trust sold 194 Medtronic shares in Q2 2026, an estimated $15.7K.
  • Medtronic made up 0.08% of Crews Bank & Trust's portfolio in Q2 2026, its #135 holding.
  • Crews Bank & Trust first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Crews Bank & Trust's Medtronic position peaked at $817K in Q1 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.